Treatment of chronic plantar fasciitis with Botulinum toxin A: preliminary clinical results.

Abstract

Based on recent results in chronic lateral epicondylitis we decided to investigate the efficacy of Botulinum toxin A (BTX-A) for treatment of chronic therapy resistant plantar fasciitis. Nine patients with an average duration of symptoms of 14 months and at least two prior conservative treatments received a one injection of 200 units of BTX-A (Dysport) subfascially into the painful area. The patients documented pain at rest and during weight-bearing after 2, 6, 10 and 14 weeks by a visual analogue scale. A significant reduction of pain during weight-bearing to about 50% was seen 6 weeks after injection. The effect was still present at the latest follow-up of 14 weeks. Similarly, the pain at rest was reduced to less than half of the initial value at any follow-up. All patients were satisfied and did not require further treatment.

• Authors: Richard Placzek, Georg Deuretzbacher, A Ludwig Meiss
• Journal: The Clinical journal of pain (Clin J Pain) Vol. 22 Issue 2 Pg. 190-2 (Feb 2006) ISSN: 0749-8047 [Print] United States
• PMID: 16428954 (Publication Type: Clinical Trial, Journal Article, Multicenter Study)

Chemical References

• Botulinum Toxins

Topics

• Adult
• Aged
• Botulinum Toxins (administration & dosage, therapeutic use)
• Chronic Disease
• Fasciitis, Plantar (drug therapy)
• Female
• Follow-Up Studies
• Humans
• Injections
• Male
• Middle Aged
• Pain Measurement
• Patient Satisfaction